Compare Heron Therapeutics Inc (HRTX) vs AT&T Inc. (T) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs AT&T Inc. — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while AT&T Inc. trades at $24.42 (market cap $167.88B). The key difference: AT&T Inc. is far larger — about 2731.1× Heron Therapeutics Inc's market cap, and AT&T Inc. pays a 4.53% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | T | |
|---|---|---|
Market Cap | $61.47M | $167.88B |
Sector | Health | Media |
52-Week High | $1.49 | $29.62 |
52-Week Low | $0.32 | $20.49 |
Enterprise Value | $168.21M | $313.20B |
Dividend Yield | — | 4.53% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About AT&T Inc.
AT&T Inc. is a communications holding company. The Company, through its subsidiaries and affiliates, provides local and long-distance phone service, wireless and data communications, Internet access and messaging, IP-based and satellite television, security services, telecommunications equipment, and directory advertising and publishing.
Read more on T →
